| 抗PD-1/PD-L1治疗在晚期难治性肺鳞癌中的疗效和安全性 |
| |
| 引用本文： | 陈茜,周建英,黎扬斯. 抗PD-1/PD-L1治疗在晚期难治性肺鳞癌中的疗效和安全性[J]. 循证医学, 2015, 15(4): 213-216. DOI: 10.3969/j.issn.1671-5144.2015.04.007 |
| |
| 作者姓名： | 陈茜 周建英 黎扬斯 |
| |
| 作者单位： | 1. 浙江大学医学院附属第一医院呼吸内科,杭州 310003; 2. 广东省人民医院肿瘤中心、广东省医学科学院、广东省肺癌研究所, 广州510080 |
| |
| 摘 要： |
|
| 关 键 词： | 肺鳞癌 Nivolumab PD-1 |
Activity and Safety,An Anti-PD-1 Immune Checkpoint Inhibitor,for Patients with Advanced,Refractory Squamous Non-Small Cell Lung Cancer |
| |
| CHEN Xi,ZHOU Jian-ying,LI Yang-si. Activity and Safety,An Anti-PD-1 Immune Checkpoint Inhibitor,for Patients with Advanced,Refractory Squamous Non-Small Cell Lung Cancer[J]. The Journal of Evidence-Based Medicine, 2015, 15(4): 213-216. DOI: 10.3969/j.issn.1671-5144.2015.04.007 |
| |
| Authors: | CHEN Xi ZHOU Jian-ying LI Yang-si |
| |
| Affiliation: | Reviewers’ address： Pneumology Department, The First Affiliated Hospital, Zhejiang University, Hangzhou 310003, China |
| |
| Abstract: | |
| |
| Keywords: | squamous non-small cell lung cancer Nivolumab PD-1 |
|
| 点击此处可从《循证医学》浏览原始摘要信息 |
|
点击此处可从《循证医学》下载全文 |
|
